VUB-16575-36490
4 vaccinations
5 coded responses
36 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 208 / MD
- Registered
- 2021-05-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-28
Dose 1 — Pfizer-BioNTech
-
2021-05-19
Registered in v-safe
-
2021-05-19
Dose 2 — Pfizer-BioNTech
- 2021-05-19
-
2021-05-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-05-21
- 2021-05-22
- 2021-05-23
- 2021-05-24
- 2021-05-25
- 2021-05-26
- 2021-06-02
- 2021-06-09
-
2021-06-16
Survey response — day 28, dose 2MedDRA: Nasopharyngitis, Respiratory tract congestion — Feeling: FairFree text: Cold: head and chest congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-23
- 2021-06-30
- 2021-08-18
-
2021-11-17
Survey response — 6 months, dose 2MedDRA: Nasopharyngitis, Norovirus infection — Feeling: GoodFree text: One cold, one episode of norovirus.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-14
Dose 3 — Moderna
-
2021-12-15
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-12-16
- 2021-12-17
- 2021-12-18
- 2021-12-19
-
2021-12-20
Survey response — days 1–6 daily, dose 3MedDRA: Dizziness — Feeling: Fair · Fatigue or tirednessFree text: Light headedMedDRA releases: 2024-11 · check-in free text available
- 2021-12-21
- 2021-12-28
- 2022-01-04
- 2022-01-11
- 2022-01-18
- 2022-01-25
-
2022-03-15
Survey response — 3 months, dose 3MedDRA: Neuropathy peripheral — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Peripheral neuropathyMedDRA releases: 2024-11 · check-in free text available
-
2022-03-15
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-16
- 2022-06-14
-
2022-09-02
Dose 4 — Pfizer-BioNTech
-
2022-09-17
Survey response — day 14, dose 4MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
- 2022-09-23
- 2022-09-30
- 2022-10-07
- 2022-10-14
- 2022-12-02
- 2023-03-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-28 | Pfizer-BioNTech | |
| 2 | 2021-05-19 | Pfizer-BioNTech | |
| 3 | 2021-12-14 | Moderna | No |
| 4 | 2022-09-02 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-15 | Unsuccessful |
Free text
Release 9 — day 28, dose 2
Symptoms: Cold: head and chest congestion
Release 10 — 6 months, dose 2
Symptoms: One cold, one episode of norovirus.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Light headed
Release 11 — 3 months, dose 3
Symptoms: Peripheral neuropathy
Release 12 — day 14, dose 4
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Neuropathy peripheral | · | · | ✓ |
| SD | Norovirus infection | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SRO | Dizziness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release